Diabetic Medicine

Dorothy Hodgkin Lecture 2008 Gastric inhibitory polypeptide (GIP) revisited: a new therapeutic target for obesity-diabetes?
pp. 759-764(6)
Author: Flatt, P. R.

Severe hypoglycaemia and glycaemic control in Type 1 diabetes: meta-analysis of multiple daily insulin injections compared with continuous subcutaneous insulin infusion
pp. 765-774(10)
Authors: Pickup, J. C.; Sutton, A. J.

Prevalence of HNF1A (MODY3) mutations in a Norwegian population (the HUNT2 Study)
pp. 775-781(7)
Authors: Eide, S. Å.; Ræder, H.; Johansson, S.; Midthjell, K.; Søvik, O.; Njølstad, P. R.; Molven, A.

Lack of pancreatic body and tail in HNF1B mutation carriers
pp. 782-787(6)
Authors: Haldorsen, I. S.; Vesterhus, M.; Ræder, H.; Jensen, D. K.; Søvik, O.; Molven, A.; Njølstad, P. R.

Can complement factors 5 and 8 and transthyretin be used as biomarkers for MODY 1 (HNF4A-MODY) and MODY 3 (HNF1A-MODY)?
pp. 788-791(4)
Authors: Karlsson, E.; Shaat, N.; Groop, L.

Antibody response to insulin in children and adolescents with newly diagnosed Type 1 diabetes
pp. 792-797(6)
Authors: Holmberg, H.; Mersebach, H.; Kanc, K.; Ludvigsson on behalf of the Insulin Aspart Study Group on Immunogenicity, J.

Serum bicarbonate, anion gap and insulin resistance in the National Health and Nutrition Examination Survey
pp. 798-804(7)
Authors: Farwell, W. R.; Taylor, E. N.

Brainstem auditory evoked potentials and middle latency auditory evoked potentials in patients with impaired glucose tolerance
pp. 805-810(6)
Authors: Yitmen, İ.; Oflazogˇlu, B.; İşak, B.; Çiprut, A.; Akdaş, F.; Tanrıdagˇ, T.; Us, Ö.

The impact of different time frames of risk communication on Type 2 diabetes patients' understanding and memory for risk of coronary heart disease and stroke
pp. 811-817(7)
Authors: Asimakopoulou, K. G.; Fox, C.; Spimpolo, J.; Marsh, S.; Skinner, T. C.

Stratified analyses for selecting appropriate target patients with diabetic peripheral neuropathy for long-term treatment with an aldose reductase inhibitor, epalrestat
pp. 818-825(8)
Authors: Hotta, N; Kawamori, R.; Atsumi, Y.; Baba, M.; Kishikawa, H.; Nakamura, J.; Oikawa, S.; Yamada, N.; Yasuda, H.; Shigeta, Y.

Lower levels of circulating IGF-I in Type 1 diabetic women with frequent severe hypoglycaemia during pregnancy
pp. 826-833(8)
Authors: Ringholm Nielsen, L.; Juul, A.; Pedersen-Bjergaard, U.; Thorsteinsson, B.; Damm, P.; Mathiesen, E. R.

Psychological distress and risk of pre-diabetes and Type 2 diabetes in a prospective study of Swedish middle-aged men and women
pp. 834-842(9)
Authors: Eriksson, A.-K.; Ekbom, A.; Granath, F.; Hilding, A.; Efendic, S.; Östenson, C.-G.

Symptoms of depression in people with impaired glucose metabolism or Type 2 diabetes mellitus: The Hoorn Study
pp. 843-849(7)
Authors: Adriaanse, M. C.; Dekker, J. M.; Heine, R. J.; Snoek, F. J.; Beekman, A. J.; Stehouwer, C. D.; Bouter, L. M.; Nijpels, G.; Pouwer, F.

Long-term adherence to statin treatment in diabetes
pp. 850-855(6)
Authors: Donnelly, L. A.; Doney, A. S. F.; Morris, A. D.; Palmer, C. N. A.; Donnan, P. T.

Levofloxacin-associated hypoglycaemia complicated by pontine myelinolysis and quadriplegia
pp. 856-859(4)
Authors: Vallurupalli, S.; Huesmann, G.; Gregory, J.; Jakoby, M. G.

Spontaneous resolution of diabetic macular oedema after discontinuation of thiazolidenediones
pp. 860-862(3)
Authors: Liazos, E.; Broadbent, D. M.; Beare, N.; Kumar, N.

Relationship between autonomic neuropathy and hypertension—are we underestimating the problem?
pp. 863-866(4)
Authors: Istenes, I.; Keresztes, K.; Hermányi, Z.; Putz, Z.; Vargha, P.; Gandhi, R.; Tesfaye, S.; Kempler, P.

Ketoacidosis occurs in both Type 1 and Type 2 diabetes— a population-based study from Northern Sweden
pp. 867-870(4)
Authors: Wang, Z. H.; Kihl-Selstam, E.; Eriksson, J. W.

New use of rosiglitazone decreased following publication of a meta-analysis suggesting harm
pp. 871-874(4)
Authors: Shah, B. R.; Juurlink, D. N.; Austin, P. C.; Mamdani, M. M.

Increased levels of monokine induced by interferon-γ (Mig) in the vitreous of patients with diabetic retinopathy
pp. 875-877(3)
Authors: Wakabayashi, Y.; Usui, Y.; Okunuki, Y.; Takeuchi, M.; Kezuka, T.; Iwasaki, T.; Goto, H.

Diabetes and anxiety in US adults: findings from the 2006 Behavioral Risk Factor Surveillance System
pp. 878-881(4)
Authors: Li, C.; Barker, L.; Ford, E. S.; Zhang, X.; Strine, T. W.; Mokdad, A. H.

Diabetic retinopathy is associated with an increased incidence of cardiovascular events in Type 2 diabetic patients
pp. 882-882(1)
Authors: Jeganathan, V. S. E.; Cheung, N.; Wong, T. Y.

Reply
pp. 882-883(2)
Author: Targher, G.

Improvement of insulin resistance after removal of a parathyroid adenoma in a Type 2 diabetic patient
pp. 883-884(2)
Author: Watanabe, Y.

Disturbed eating behaviours and glycaemic control in young subjects with Type 1 diabetes transferred from a paediatric to an adult diabetes unit
pp. 884-885(2)
Authors: Giménez, M.; Lara, M.; Vidal, M.; Jansà, M.; Conget, I.

Abdominal pain in a man with diabetes
pp. 885-887(3)
Authors: Wong, S. H.; Steiger, M. J.